Results: 1-8 |
Results: 8

Authors: Wang, ES Maslak, P Cathcart, K Jurcic, JG
Citation: Es. Wang et al., Acute myeloid leukemia with t(5;18)(q35;q21), CANC GENET, 127(1), 2001, pp. 71-73

Authors: Noy, A Verma, R Glenn, M Maslak, P Rahman, ZU Keenan, JR Weiss, M Filippa, D Zelenetz, AD
Citation: A. Noy et al., Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol, BLOOD, 97(7), 2001, pp. 1929-1936

Authors: Maslak, P Scheinberg, D
Citation: P. Maslak et D. Scheinberg, Targeted therapies for the myeloid leukaemias, EXPERT OP I, 9(6), 2000, pp. 1197-1205

Authors: O'Donnell, MR Appelbaum, FR Baer, MR Carabasi, MH Coutre, SE Erba, HP Estey, E Glenn, MJ Kraut, EH Maslak, P Millenson, M Miller, CB Saba, HI Stone, R Tallman, MS
Citation: Mr. O'Donnell et al., NCCN Practice Guidelines for acute myelogenous leukemia, ONCOLOGY-NY, 14(11A), 2000, pp. 53-61

Authors: Weiss, MA Glenn, M Maslak, P Rahman, Z Noy, A Zelenetz, A Scheinberg, DA Golde, DW
Citation: Ma. Weiss et al., Consolidation therapy with high-dose cyclophosphamide improves the qualityof response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy, LEUKEMIA, 14(9), 2000, pp. 1577-1582

Authors: Schwartz, GK Ilson, D Saltz, L O'Reilly, E Tong, W Maslak, P Werner, J Perkins, P Stoltz, M Kelsen, D
Citation: Gk. Schwartz et al., Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma, J CL ONCOL, 19(7), 2000, pp. 1985-1992

Authors: Maslak, P McGuinn, JM
Citation: P. Maslak et Jm. Mcguinn, Exergonic fragmentations in photogenerated zwitterions, CHEM COMMUN, (24), 1999, pp. 2467-2468

Authors: Maslak, P Varadarajan, S Burkey, JD
Citation: P. Maslak et al., Synthesis, structure, and nucleophile-induced rearrangements of spiroketones, J ORG CHEM, 64(22), 1999, pp. 8201-8209
Risultati: 1-8 |